CI_ChemClass
CI_with
has_DoseForm
has_Ingredient
has_MoA
has_PE
may_treat
drug associated with AE
Cardiac Output, Low [Disease/Finding]
Hypersensitivity [Disease/Finding]
Discrete Subaortic Stenosis [Disease/Finding]
Sulfites [Chemical/Ingredient]
Positive Chronotropy [PE]
Positive Inotropy [PE]
Adrenergic beta1-Agonists [MoA]
[AU100] SYMPATHOMIMETICS (ADRENERGICS)
Injectable Solution [Dose Form]
DOBUTAMINE HYDROCHLORIDE
DOBUTAMINE HCL 12.5MG/ML INJ [VA Product]
MG/ML
C39810
盐酸多巴酚丁胺注射液
VA Product
<Product_Component>DOBUTAMINE HYDROCHLORIDE</Product_Component><Strength>12.5</Strength><Unit>MG/ML</Unit><VA.IEN>134</VA.IEN>
204395
注射用盐酸多巴酚丁胺
DOBUTAMINE HCL 12.5MG/ML INJ
N0000149567
盐酸多巴酚丁胺葡萄糖注射液
0
<VANDF_Record>50.68^702^Active/Master</VANDF_Record><VA_File>50.68</VA_File><VA_IEN>702</VA_IEN><VA_Status>Active/Master</VA_Status>
Dobutamine 12.5 MG/ML Injectable Solution
DOBUTAMINE INJ
DOBUTAMINE HCL 12.5MG/ML INJ
C0702304
12.5
4001313
Dobutamine Hydrochloride [Chemical/Ingredient]
phlebitis AE
angina pectoris AE
dyspnea AE
headache AE
hypertension AE
chest pain AE
palpitation AE
hypotension AE
increased heart rate AE
nausea AE
Glascow coma scale abnormal AE
tachypnea AE
thrombocytopenia AE
ventricular extrasystoles AE
skin necrosis AE
ventricular ectopic beats AE
sudden fall of blood pressure AE
serum potassium concentration of moderately reduced
DOBUTAMINE HCL 12.5MG/ML INJ [VA Product]
DOBUTAMINE HCL 12.5MG/ML INJ
盐酸多巴酚丁胺注射液
VA Product
N0000149567
<Product_Component>DOBUTAMINE HYDROCHLORIDE</Product_Component><Strength>12.5</Strength><Unit>MG/ML</Unit><VA.IEN>134</VA.IEN>
MG/ML
<VANDF_Record>50.68^702^Active/Master</VANDF_Record><VA_File>50.68</VA_File><VA_IEN>702</VA_IEN><VA_Status>Active/Master</VA_Status>
Dobutamine 12.5 MG/ML Injectable Solution
盐酸多巴酚丁胺葡萄糖注射液
204395
C39810
DOBUTAMINE INJ
DOBUTAMINE HCL 12.5MG/ML INJ
0
C0702304
注射用盐酸多巴酚丁胺
12.5
4001313